Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Shares Issued (2019 - 2025)

Historic Shares Issued for Benitec Biopharma (BNTC) over the last 6 years, with Q2 2025 value amounting to $1000.0.

  • Benitec Biopharma's Shares Issued fell 9999.75% to $1000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $70.4 million, marking a year-over-year decrease of 65.18%. This contributed to the annual value of $30.5 million for FY2025, which is 5702.78% down from last year.
  • Per Benitec Biopharma's latest filing, its Shares Issued stood at $1000.0 for Q2 2025, which was down 9999.75% from $30.5 million recorded in Q1 2025.
  • Benitec Biopharma's 5-year Shares Issued high stood at $40.0 million for Q2 2024, and its period low was -$39000.0 during Q1 2024.
  • For the 5-year period, Benitec Biopharma's Shares Issued averaged around $14.8 million, with its median value being $14.3 million (2021).
  • The largest annual percentage gain for Benitec Biopharma's Shares Issued in the last 5 years was 7820000.0% (2025), contrasted with its biggest fall of 9999.75% (2025).
  • Over the past 5 years, Benitec Biopharma's Shares Issued (Quarter) stood at $14.3 million in 2021, then increased by 25.48% to $17.9 million in 2022, then tumbled by 99.78% to $39000.0 in 2023, then soared by 102464.1% to $40.0 million in 2024, then crashed by 100.0% to $1000.0 in 2025.
  • Its Shares Issued was $1000.0 in Q2 2025, compared to $30.5 million in Q1 2025 and $40.0 million in Q2 2024.